Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001535610-25-000010
Filing Date
2025-01-03
Accepted
2025-01-03 12:41:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7664
  Complete submission text file 0001535610-25-000010.txt   9345
Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Subject) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-88855 | Film No.: 25504743
SIC: 0100 Agricultural Production-Crops
(CF Office: 08 Industrial Applications and Services)

Mailing Address 7012 FISHER ISLAND DR MIAMI BEACH FL 33109
Business Address 7012 FISHER ISLAND DR MIAMI BEACH FL 33109 646-307-4500
SABBY MANAGEMENT, LLC (Filed by) CIK: 0001535610 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A